NOVABAY PHARMACEUTICALS INC (NBY) 0.11 0 (0%)

0.11 0 (0%)

US66987P2011 - Common Stock - After market: 0.1079 0 (-1.91%)

Analysts have set a mean price target of 2.86. This target is 2496.36% above the current price.

NBY was analyzed by 6 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NBY.

In the previous month the buy percentage consensus was at a similar level.

NBY was analyzed by 6 analysts. More opinions would make the average more meaningful.

Price

Low

Median

Mean

High

0.11

1.87

2.86

3.94

1,598.64%

2,496.36%

3,479.55%

Date	Firm	Action	Rating
2022-05-20	Ascendiant Capital	Maintains	Buy

Find the competitors with the best analyst ratings on the USA